<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3e/6924106/b810646d64c2/ol-19-01-0317-g00.jpg"/> </div> <div class="text-side"> <h1>LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma.</h1> <p>Representative immunohistochemical staining patterns showing the levels of lysosome-associated protein transmembrane-4β-35 (LAPTM4B-35) in 4 µm thick paraffin-embedded sections of normal and tumour tissue samples from patients with salivary adenoid cystic carcinoma. (A and B) → indicates serous acini, ➡ indicates intercalated ducts, ð indicates secretory/striated ducts. (C and D) → indicates excretory duct. (E and F) → indicates mucous acini. Low expression of LAPTM4B in salivary adenoid cystic carcinoma (SACC, 1H, 1G for H&amp;E), moderate expression of LAPTM4B-35 (1J, 1I for H&amp;E) and high expression of LAPTM4B-35 (1L, IK for H&amp;E). Original magnification, ×100.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31897144/" target="_blank">31897144</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>